Revised bill to curb Kentucky’s pharmacy middlemen advances after major changes
A bill aimed at cutting corporate middlemen out of Kentucky’s $1.7 billion-a-year Medicaid prescription drug business passed the Senate on Thursday with changes to ease concerns it could disrupt a separate funding stream for hospitals and community health clinics.
